Turkey: Recent Developments And Legal Landscape On Procurement Of Medicines From Abroad

I - Introduction and Recent News on the Assignment of the Duties to Social Security Institution

In Turkey, import and sale of medicines are subject to licensing requirements of the Ministry of Health ("Ministry"). The principle is that medicines which are not licensed in Turkey cannot be put on the Turkish market. "Procurement of medicines from abroad" mechanism, on the other hand, brings an exception to this rule.

With the "Procurement of medicines from abroad" process which is regulated under the Guidelines for Procurement of Medicines from Abroad ("Guidelines"), as published on the Ministry's website, the Ministry paves the way for a distinct mechanism allowing the procurement of medicines that are licensed but not accessible in Turkey for various reasons (e.g. stock-out) or medicines which are not duly licensed in Turkey, on prescription basis or in emergent cases, collectively.

The Ministry's current list of approved suppliers, as attached to Annex 8 of the Guidelines1, points out the Turkish Pharmacy Association ("TEB") as the sole supplier authorized to procure medicines from abroad. Although TEB recaptured its role as the sole supplier following a public feud with the Ministry2, there are news3 appeared this year on the media alleging that Social Security Institution ("SSI") will take over TEB's authority to procure medicines from abroad. Apart from this current media coverage, the legislation in force stands the same and TEB reserves its title as the sole authorized supplier.

II - Overview of the Ministry of Health's Guidelines

The Ministry's process of "Procurement of Medicines from Abroad" is regulated under the Guidelines4. The Guidelines, while setting forth the criteria for procurement, outlines the rules to be fulfilled both by patients and the supplier approved for the procurement.

In light of the Guidelines, medicines which are not licensed in Turkey and/or cannot be found in market (though being licensed), can be procured from abroad on prescription basis or, in emergent cases, collectively. Lists of medicines that can be procured from abroad as well as the approved suppliers authorized to procure such medicines are published on the Ministry's website. All of the substances listed under the list can only be imported by those approved suppliers. This said, currently TEB, being the sole entity under the list, holds the title of the sole supplier authorized for the procurement.

According to the Guidelines, during the import of these medicines, a Control Certificate should also be prepared by the Ministry for importation of the medicines containing the active substances listed under the Ministry's "Active Substance List"5. Doctor prescription and patient information form are also sought during the procurement process each time. Also, procurement consent for the substances is individual for each patient.6 A consent obtained for a specific patient does not set an example for other patients with same diagnoses yet with different clinical courses, as accepted by the Ministry.

III - Criteria for Procurement

In light of the Guidelines, TEB can procure the medicines from abroad which are not licensed in Turkey or cannot be found in Turkey despite being licensed, in exceptional cases where all treatment options in Turkey have been exhausted or where such options cannot be exhausted in certain patients, for the diagnoses and the treatment of diseases. These medicines can only be procured by TEB by complying with the following order:

  1. Medicines approved and marketed by FDA/EMA or manufactured, licensed and marketed in countries which are member to Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme, should be procured.
  2. In case the medicine cannot be found in or procured from the countries under (i), the names of the medicines manufactured and used in countries other than the ones listed under (i) can be added to the list of "Medicines to be Procured from Abroad", with the approval of the Chairman of the Turkish Medicine and Medical Device Institution ("Institution")7, by collecting the opinion of the relevant scientific commission.
  3. During the application to be made by TEB to the Institution for the inclusion of the medicines not licensed by FDA/EMA to the "Medicines to be Procured from Abroad" list, the following documentation should be submitted:

    1. Certificate of Pharmaceutical Product for the medicine
    2. Medicine information (including safety information) and letter or corporate e-mail from the manufacturing company which includes the country information where the medicine is used.
    3. In cases where the documentation set forth in (a) and (b) cannot be procured and attested by TEB, letter of corporate e-mail regarding medicine information (including safety information) from the foreign supplier warehouse.

To that end, TEB would be the responsible authority for the duly procurement and supply of the foreign medicines and should comply with the foregoing criteria, in respective order, for procurement. While the principle is to procure the product on a prescription basis (with the request of the doctor), TEB can stock the medicines listed under Medicines to be Procured from Abroad, as per the Guidelines.

IV - Discussion of Authorization for Procurement

Back in 2013, the Ministry gave the authority to procure medicines from abroad to a number of pharmaceutical warehouses by way of including them to the authorized suppliers list, which triggered controversy between TEB and the Ministry.

Following certain public announcements criticizing the Institution's approach8 and failed negotiations with the Institution, TEB has initiated a lawsuit against the Institution before the Council of State alleging that the amendment made in the legislation which paves the way for other suppliers to enter into protocols with the Institution for the procurement process is unlawful and breaches the protocol provisions between TEB and the Institution. As a result, the Council of State has granted a motion for stay of execution for the Institution's amendment in the legislation9.

In light of the foregoing, the Institution re-amended the Guidelines and published the revised authorized suppliers list in its website with the following note;

"As per 15th Department of Council of State's motion for stay of execution, procurement activities of pharmaceutical warehouses previously authorized by our Institution for procurement medicines from abroad, have been ceased as of 30.04.2016."

V - List of Medicines That Can Be Procured From Abroad

The active substance sought for the medicines to be procured from abroad are listed on an excel sheet announced weekly on the Institutions website10. As per Article 5 of the Guidelines, except for the active substances marked as the "Medicines that can only be imported with the Ministry's consent", the Ministry does not seek an import permit for the active substances listed on the first tab of the excel sheet.

For the active substances that are not included in the Lists of medicines that can be procured from abroad, an application can be made to the Institution with the documents listed in Article 5 (4) of the Guidelines.

VI - Reimbursement of Procured Medicines

In Turkey, SSI deals with the reimbursement front of the medicines procured from abroad. In other words, the Ministry is the authority for the import of the medicine, whereas the SSI is the relevant authority for the reimbursement thereof. The Ministry's current list of approved suppliers, points out the TEB as the sole supplier which has arrangements with the SSI for reimbursement. There is a protocol in place between SSI and TEB for reimbursement since 2007.11

VII - Conclusion

"Procurement of medicines from abroad" process without doubt holds great importance for the health sector and patients seeking medicines that are short in the Turkish market. Regardless of the controversies as to suppliers of these medicines, the Ministry continues to lay the way open for the exporters willing to contribute in procurement of medicines in to the Turkish market.


1. See at http://www.titck.gov.tr/PortalAdmin/Uploads/UnitPages/tedarikci_depolar_listesi_%2029.01.2016.pdf (latest access on December 6th, 2016)

2. See Subtitle IV below.

3. See at http://www.haberturk.com/saglik/haber/1267805-yurtdisindan-ilaci-artik-sgk-getirecek (latest access on December 6th, 2016) and http://www.dunya.com/ekonomi/sgk-yurtdisindan-ilac-getirme-isini-buyuk-oranda-ustlenecek-haberi-320214 (latest access on December 6th, 2016)

4. See at http://www.titck.gov.tr/Mevzuat/MevzuatGetir?id=2649 (latest access on December 6th, 2016)

5. Article 7 (3) of the Guidelines for Procurement of Medicines from Abroad.

6. Article 6 (10) of the Guidelines for Procurement of Medicines from Abroad.

7. Turkish Medicine and Medical Device Institution is a division of the Ministry of Health.

8. See at (latest access on December 6th, 2016) and http://teb.org.tr/news/6684/%C4%B0thal-%C4%B0la%C3%A7-Temini-Konusunda-SGK-ile-Anla%C5%9Fmas%C4%B1-Olan-Tek-Tedarik%C3%A7i-TEB%EF%BF%BD%EF%BF%BDdir (latest access on December 6th, 2016)

9. TEB's announcement as to Department of Council's verdict can be found at http://www.teb.org.tr/news/6901/Yurtd%C4%B1%C5%9F%C4%B1ndan-%C4%B0la%C3%A7-Temini-Yetkisi-Verilen-Tedarik%C3%A7iler-Konusunda-T%C4%B0TCKya-A%C3%A7t%C4%B1%C4%9F%C4%B1m%C4%B1z-Dava-Sonu%C3%A7land%C4%B1 (latest access on December 6th, 2016)

10. As of the publication date of this article, the most recent list is published on December 2nd 2016. See the current list at http://www.titck.gov.tr/Yurtd%C4%B1%C5%9F%C4%B1%C4%B0la%C3%A7  (latest access on December 6th, 2016)

11. See signed copy of the protocol in Turkish at http://www.istanbuleczaciodasi.org.tr/upload/pdf/20120203_protokol.pdf (latest access on December 6th, 2016)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.